79,363 results match your criteria Diabetes Mellitus Type 1


Frequency of Reduced Left Ventricular Contractile Efficiency and Discoordinated Myocardial Relaxation in Patients Aged 16 to 21 Years With Type 1 Diabetes Mellitus (from the Emerald Study).

Am J Cardiol 2020 Aug 13;128:45-53. Epub 2020 May 13.

Section of Pediatric Endocrinology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado; Division of Nephrology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.

Early-onset cardiomyopathy is a major concern for people with type 1 diabetes mellitus (DM). Studies examining myocardial deformation indices early in the disease process in people with have provided conflicting results. Accordingly, the objective was to examine left ventricular (LV) function in adolescents with type 1 DM using novel measures of cardiomyopathy, termed ventricular discoordination indices, including systolic stretch fraction (SSF), and our newly developed diastolic relaxation fraction (DRF). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2020.04.041DOI Listing

Implementing Telehealth in Pediatric Type 1 Diabetes Mellitus.

Pediatr Clin North Am 2020 Aug 11;67(4):661-664. Epub 2020 Jun 11.

Division of Endocrinology, Department of Pediatrics, Children's Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA; Keck School of Medicine of the University of Southern California, 1975 Zonal Avenue, Los Angeles, CA 90089, USA. Electronic address:

Management of type 1 diabetes mellitus for pediatric and young adult patients is well suited for telehealth. Diabetes management requires frequent communication with health care providers as well as the interpretation of many types of data that can be measured in the home and shared virtually to the provider by the patient. Telehealth technologies allow for a safe alternative and/or addition to in-person care for youth with diabetes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcl.2020.04.009DOI Listing

Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.

Diabetes Res Clin Pract 2020 Jul 7:108307. Epub 2020 Jul 7.

1(st) Paediatric Department, Aristotle University, Ippokration General Hospital, 49(th) Konstantinoupoleos str, P.C.:54642, Thessaloniki, GREECE.

Aims: On the 10 of March, Greece imposed the closure of schools and universities and a full lockdown a few days later in order to counter the spread of the coronavirus outbreak. Our aim was to monitor the effect of the coronavirus lockdown in diabetes management in children with Type 1 Diabetes Mellitus (T1DM) wearing insulin pump equipped with continuous glucose monitoring system.

Methods: In 34 children with T1DM on Medtronic 640G insulin pump equipped with the Enlite Sensor uploaded CareLink data were categorized in 2 three-week periods before and after the 10 of March. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2020.108307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340587PMC

Insulin protects against type 1 diabetes mellitus-induced ultrastructural abnormalities of pancreatic islet microcirculation.

Microscopy (Oxf) 2020 Jul 10. Epub 2020 Jul 10.

Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China.

Pancreatic islet microcirculation, consisting of pancreatic islet microvascular endothelial cells (IMECs) and pericytes (IMPCs), provides crucial support for the physiological function of pancreatic islet. Emerging evidence suggests that pancreatic islet microcirculation is impaired in type 1 diabetes mellitus (T1DM). Here, we investigated the potential ultrastructural protective effects of insulin against streptozotocin (STZ)-induced ultrastructural abnormalities of the pancreatic islet microcirculation in T1DM mouse model. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jmicro/dfaa036DOI Listing

Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS).

Ther Adv Endocrinol Metab 2020 27;11:2042018820937217. Epub 2020 Jun 27.

Clinical Study Unit, Sanofi Synthelabo India Limited, Mumbai, Maharashtra, India.

Objective: To assess the real-world management practices of subjects with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in India.

Methods: This cross-sectional study was conducted between 7 March 2016 and 15 May 2016 in India as part of the seventh wave (2016) of the International Diabetes Management Practices Study (IDMPS). Adult subjects with T1DM or T2DM visiting physicians during a 2-week recruitment period were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2042018820937217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325532PMC

Non-immune-mediated versus immune-mediated type 1 diabetes: diagnosis and long-term differences-retrospective analysis.

Diabetol Metab Syndr 2020 6;12:56. Epub 2020 Jul 6.

Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitário de Coimbra EPE, Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal.

Background: The American Diabetes Association proposed two subcategories for type 1 diabetes mellitus: type 1A or immune-mediated diabetes (IDM) and type 1B or idiopathic diabetes. The absence of β-cell autoimmune markers, permanent insulinopenia and prone to ketoacidosis define the second category, whose pathogenesis remains unclear. Only a minority of patients fall into this category, also designated non-immune-mediated (NIDM), which is considered by several authors similar to type 2 diabetes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13098-020-00563-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336466PMC

An Approach to diabetic ketoacidosis in an emergency setting.

Rev Recent Clin Trials 2020 Jul 9. Epub 2020 Jul 9.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 8 - 00168 Roma. Italy.

Background: Diabetic Ketoacidosis (DKA) is one of the most commonly encountered diabetic complication emergencies. It typically affects people with type 1 diabetes at the onset of the disease. It can also affect people with type 2 diabetes, although this is uncommon. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574887115666200709172402DOI Listing

Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis.

Cell Prolif 2020 Jul 9:e12866. Epub 2020 Jul 9.

Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Objectives: High glucose (HG)-mediated bone marrow mesenchymal stem cell (BMSC) dysfunction plays a key role in impaired bone formation induced by type 1 diabetes mellitus (T1DM). Morroniside is an iridoid glycoside derived from the Chinese herb Cornus officinalis, and it has abundant biological activities associated with cell metabolism and tissue regeneration. However, the effects and underlying mechanisms of morroniside on HG-induced BMSC dysfunction remain poorly understood. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cpr.12866DOI Listing

Current progress in stem cell therapy for type 1 diabetes mellitus.

Stem Cell Res Ther 2020 Jul 8;11(1):275. Epub 2020 Jul 8.

Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Center for Translational Medicine and School of Preclinical Medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China.

Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells; as a result, the body becomes insulin deficient and hyperglycemic. Administration or injection of exogenous insulin cannot mimic the endogenous insulin secreted by a healthy pancreas. Pancreas and islet transplantation have emerged as promising treatments for reconstructing the normal regulation of blood glucose in T1DM patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13287-020-01793-6DOI Listing

Adeno-Associated Viral Transfer of Glyoxalase-1 Blunts Carbonyl and Oxidative Stresses in Hearts of Type 1 Diabetic Rats.

Antioxidants (Basel) 2020 Jul 6;9(7). Epub 2020 Jul 6.

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA.

Accumulation of methylglyoxal (MG) arising from downregulation of its primary degrading enzyme glyoxalase-1 (Glo1) is an underlying cause of diabetic cardiomyopathy (DC). This study investigated if expressing Glo1 in rat hearts shortly after the onset of Type 1 diabetes mellitus (T1DM) would blunt the development of DC employing the streptozotocin-induced T1DM rat model, an adeno-associated virus containing Glo1 driven by the endothelin-1 promoter (AAV2/9-Endo-Glo1), echocardiography, video edge, confocal imaging, and biochemical/histopathological assays. After eight weeks of T1DM, rats developed DC characterized by a decreased E:A ratio, fractional shortening, and ejection fraction, and increased isovolumetric relaxation time, E: e' ratio, and circumferential and longitudinal strains. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/antiox9070592DOI Listing

Ensemble methods in combination with compartment models for blood glucose level prediction in type 1 diabetes mellitus.

Comput Methods Programs Biomed 2020 Jun 27;196:105628. Epub 2020 Jun 27.

FN Motol University Hospital, Prague, Czech Republic.

Backgroung: Type 1 diabetes is a disease that adversely affects the daily life of a large percentage of people worldwide. Daily glucose levels regulation and useful advices provided to patients regarding their diet are essential for diabetes treatment. For this reason, the interest of the academic community has focused on developing innovative systems, such as decision support systems, based on glucose prediction algorithms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmpb.2020.105628DOI Listing

Sleep, self-management, neurocognitive function, and glycemia in emerging adults with Type 1 diabetes mellitus: A research protocol.

Res Nurs Health 2020 Jul 8. Epub 2020 Jul 8.

School of Nursing and School of Medicine, Yale University, West Haven, Connecticut.

Type 1 Diabetes (T1D) affects 1.6 million Americans, and only 14% of emerging adults ages 18-25 years achieve targets for glycemic control (A1C < 7.0%). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nur.22051DOI Listing

A Tale of Immune-Related Adverse Events With Sequential Trials of Checkpoint Inhibitors in a Patient With Metastatic Renal Cell Carcinoma.

Cureus 2020 Jun 1;12(6):e8395. Epub 2020 Jun 1.

Internal Medicine, Yale University School of Medicine, New Haven, USA.

Immune checkpoint inhibitor (CPI) therapy is approved for the treatment of many cancers. As its use becomes more prevalent, sequential trials with different CPIs as monotherapy or combination therapy will become more common. It is thought that the increased cumulative dose of CPIs over multiple trials increases the risk of immune-related adverse events (irAEs). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.8395DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331908PMC

Acute mountain sickness induced diabetic ketoacidosis managed with hemodialysis: A case report.

Ann Med Surg (Lond) 2020 Aug 13;56:165-168. Epub 2020 Jun 13.

Professor, Department of Anaesthesiology, Institute of Medicine, Maharajgunj, Kathmandu, Nepal.

Introduction: The risk of developing ketoacidosis in patients with type 1 diabetes at high altitude is high. Anorexia associated with acute mountain sickness, dehydration and additional exercise associated with climbing exacerbates the generation of ketones and the development of ketoacidosis.

Case Presentation: A 33-year-old gentleman with known history of uncontrolled type 1 diabetes mellitus trekked to Everest Base Camp at an altitude of 3440 m and became unwell. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amsu.2020.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330143PMC

Disrupted Regional Cerebral Blood Flow in Children With Newly-Diagnosed Type 1 Diabetes Mellitus: An Arterial Spin Labeling Perfusion Magnetic Resonance Imaging Study.

Front Neurol 2020 19;11:572. Epub 2020 Jun 19.

Department of Radiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Diabetes is associated with cerebral vascular dysfunction and increased vascular cognitive impairment. The objective of this study was to use arterial spin labeling (ASL) perfusion-weighted magnetic resonance imaging to investigate whether cerebral perfusion was changed in newly-diagnosed children with type 1 diabetes mellitus (T1DM) and the possible relationship between aberrant cerebral blood flow (CBF) with cognitive as well as clinical variables. Between January 2017 and February 2018, 34 children with newly-diagnosed T1DM and 34 age, gender, and education-matched healthy controls were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2020.00572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316953PMC

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia.

BMJ Open Diabetes Res Care 2020 Jul;8(1)

Endocrinology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Introduction: Impaired awareness of hypoglycemia (IAH) is a common complication in patients with type-1 diabetes (T1D). IAH is a major risk factor for severe hypoglycemic events, leading to adverse clinical consequences and cerebral damage. Non-invasive, cost-effective, and logistically efficient biomarkers for this condition have not been validated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjdrc-2020-001516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342474PMC

Nighttime Hypoglycemia in Children with Type 1 Diabetes after one Day of Football Tournament.

Int J Sports Med 2020 Jul 7. Epub 2020 Jul 7.

Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland.

The aim of the study was to investigate factors related to the occurrence of nighttime hypoglycemia after a football tournament in children with type 1 diabetes mellitus. The multicenter study (GoalDiab study) included 189 children and adolescents with type 1 diabetes mellitus, from 11 diabetes care centers in Poland. Hypoglycemia was defined according to the International Hypoglycemia Study Group Statement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1192-5992DOI Listing

Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity?

Curr Obes Rep 2020 Jul 6. Epub 2020 Jul 6.

Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, Goudi, 11527, Athens, Greece.

Purpose Of Review: During the last decades, obesity and autoimmune disorders have shown a parallel significant rise in industrialized countries. This review aims at providing a comprehensive update of the relationship between the adipose tissue in obesity and autoimmune disorders, highlighting the underlying mechanisms with a particular emphasis on adipokines and pro-inflammatory cytokines, the impaired B cell activity, and the production of natural and pathogenic autoantibody repertoire in the context of obesity.

Recent Findings: Obesity is related to a higher risk of rheumatoid arthritis, psoriasis and psoriatic arthritis, multiple sclerosis, and Hashimoto's thyroiditis, while it may promote inflammatory bowel disorders and type 1 diabetes mellitus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13679-020-00397-8DOI Listing

Fluid overload is an independent predictor of atrial fibrillation in end-stage renal disease: A prospective study using insertable cardiac and body composition monitors
.

Clin Nephrol 2020 Jul 7. Epub 2020 Jul 7.

Background: Fluid overload and atrial fibrillation (AF) are frequently encountered in patients with end-stage renal disease (ESRD). We used subcutaneously insertable cardiac monitors (ICM) to detect AF and associated it with the hydration status, determined with a body composition monitor (BCM) in dialysis patients.

Materials And Methods: 69 patients were recruited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5414/CN109997DOI Listing

Mothers and Fathers Parenting Stress and Their Perception of Children's Psychosocial Functioning in Paediatric Diabetes: A Pilot Study.

Int J Environ Res Public Health 2020 Jul 1;17(13). Epub 2020 Jul 1.

Pediatric Diabetes and Metabolic Disorders Unit, Department of Surgery, Dentistry, Pediatrics and Gynaecology, University-Hospital of Verona, 37126 Verona, Italy.

(1) : In the context of a child with Type 1 Diabetes Mellitus (T1DM), the rearrangement of the family's lifestyle can account for an increased risk of experiencing psychosocial problems for both child and parents. Those few studies on pediatric diabetes, which focused on parents' perception of children's psychological strengths and weaknesses, reported significantly higher rates of children's emotional and conduct problems associated with an imbalance in the Hemoglobin A1c (HbA1c). The main aim of this paper was to assess the role of parental perception of children's psychosocial symptoms as a mediator of the perceived parenting stress, considering mother and father separately. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph17134734DOI Listing

Persistent cardiac arrest caused by profound hypokalaemia after large-dose insulin injection in a young man with type 1 diabetes mellitus: successful rescue with extracorporeal membrane oxygenation and subsequent ventricular assist device.

Cardiovasc J Afr 2020 Jul 6;31:1-4. Epub 2020 Jul 6.

Division of Cardiovascular Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Email:

A 28-year-old man who had a history of type 1 diabetes mellitus with poor medication compliance was referred to the emergency department of our institute with suspected diabetic ketoacidosis. The patient developed sudden cardiac arrest following continuous insulin administration. Laboratory data revealed severe hypokalaemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5830/CVJA-2020-018DOI Listing

Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.

J Neurooncol 2020 Jul 5. Epub 2020 Jul 5.

Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.

Introduction: Immune checkpoint inhibition through PD-1 and CTLA-4 blockade has shown efficacy in some adult malignancies and generated interest in pediatrics, including central nervous system (CNS) tumors. We describe our experience with immune checkpoint inhibition in recurrent/refractory pediatric CNS tumors.

Methods: We performed a retrospective chart review of pediatric patients with recurrent or refractory CNS tumors treated with ipilimumab, nivolumab and/or pembrolizumab at Dana-Farber/Boston Children's Hospital between 2018 and 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-020-03578-6DOI Listing

Saudi children with celiac disease: are they at risk of developing type-1 diabetes mellitus?

J Pediatr Endocrinol Metab 2020 Jul 5. Epub 2020 Jul 5.

Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Objectives Patients with type-1 diabetes mellitus (T1DM) and celiac disease (CeD) share the same genetic susceptibility alleles. The diabetes-associated autoantibodies (DAA) may be detected in CeD patients. The aim of this study is to describe the prevalence of DAA in children with CeD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem-2019-0588DOI Listing
July 2020
0.711 Impact Factor

A new screening strategy and whole-exome sequencing for the early diagnosis of maturity-onset diabetes of the young.

Diabetes Metab Res Rev 2020 Jul 4:e3381. Epub 2020 Jul 4.

Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Aims: This study aimed to establish a systematic screening strategy to select candidates for genetic testing among patients with maturity-onset diabetes of the young (MODY) and to accomplish early diagnosis of MODY.

Materials And Methods: We enrolled 1478 sporadic patients from the outpatient department of Endocrinology. Out of the1478 patients, 1279 participants were successfully screened according to the "AACM" strategy, which includes the age of onset, autoantibody to islet antigen, C-peptide, and metabolic syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dmrr.3381DOI Listing

Celiac disease screening in children and adolescents with type1 diabetes mellitus: What test should be performed?

Endocrinol Diabetes Nutr 2020 Jun 30. Epub 2020 Jun 30.

Unidad de Gastroenterología, Servicio de Pediatría, Hospital Universitario Ramón y Cajal. Departamento de Medicina y Especialidades Médicas, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, España.

Introduction: Children and adolescents with type1 diabetes mellitus (T1DM) are at high risk for the development of celiac disease (CD) because of the common genetic characteristics of both conditions. The study objectives were to investigate the frequency of the human leukocyte antigen system (HLA) for CD in pediatric T1DM patients and to determine whether HLA testing is suitable for CD screening in that population and is cost-effective as compared to serological screening for CD.

Patients And Methods: A retrospective, descriptive study was conducted in 296 patients (148 girls; 148 boys) with T1DM aged <18years who attended a hospital in Madrid. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.endinu.2020.03.007DOI Listing

Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic renal cell carcinoma.

BMJ Case Rep 2020 Jul 2;13(7). Epub 2020 Jul 2.

Department of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA

Checkpoint inhibitor immunotherapy has revolutionised cancer treatment since its inception. During an inflammatory response, activated cytotoxic T cells expressing programmed cell death protein 1 (PD-1) interact with programmed cell death-ligand 1 (PD-L1) on peripheral tissues to thwart an autoimmune reaction. Cancer cells upregulate PD-L1 expression to evade the immune system and are vulnerable to attack in the presence of PD-1 or PD-L1 checkpoint inhibitors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-233842DOI Listing

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups.

Hum Vaccin Immunother 2020 Jul 2:1-8. Epub 2020 Jul 2.

Leuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Upon exposure to vaccine-preventable diseases, certain individuals are at increased risk for complications due to preexisting diseases, age or immunosuppressive treatment. Vaccination against influenza, pneumococcal disease and hepatitis B (for some groups) is advised in addition to standard vaccination against diphtheria, tetanus and pertussis. We estimated the vaccination coverage and determinants of recommended vaccinations in patients with diabetes mellitus type 1 (n = 173) and type 2 (n = 177), chronic kidney disease (CKD) (n = 138), heart failure (n = 200), chronic obstructive pulmonary disease (COPD) (n = 187), HIV (n = 201) or solid organ transplantation (SOT) (n = 201) in a monocentric study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21645515.2020.1763739DOI Listing

Assessing Prevalence of Hypoglycemia in a Medical Transcription Database.

Diabetes Metab Syndr Obes 2020 24;13:2209-2216. Epub 2020 Jun 24.

Novo Nordisk Inc., Plainsboro, NJ, USA.

Purpose: The prevalence of hypoglycemia in patients with diabetes mellitus is likely underreported, particularly with regard to non-severe episodes, and representative estimates require more detailed data than claims or typical electronic health record (EHR) databases provide. This study examines the prevalence of hypoglycemia as identified in a medical transcription database.

Patients And Methods: The Amplity Insights database contains medical content dictated by providers detailing patient encounters with health care professionals (HCPs) from across the United States. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DMSO.S235298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322136PMC

Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat.

J Mol Med (Berl) 2020 Jun 30. Epub 2020 Jun 30.

Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.

Proinflammatory cytokines released from the pancreatic islet immune cell infiltrate in type 1 diabetes (T1D) cause insulinopenia as a result of severe beta cell loss due to apoptosis. Diabetes prevention strategies targeting different cytokines with antibodies in combination with a T cell antibody, anti-TCR, have been assessed for therapy success in the LEW.1AR1-iddm (IDDM) rat, an animal model of human T1D. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-020-01941-8DOI Listing

Effects of C-Peptide Replacement Therapy on Bone Microarchitecture Parameters in Streptozotocin-Diabetic Rats.

Calcif Tissue Int 2020 Jun 30. Epub 2020 Jun 30.

Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, Viale S. Venuta, 88100, Catanzaro, Italy.

C-peptide therapy protects against diabetic micro- and macrovascular damages and neuropatic complications. However, to date, the role of C-peptide in preventing diabetes-related bone loss has not been investigated. Our aim was to evaluate if C-peptide infusion improves bone quality in diabetic rats. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-020-00716-0DOI Listing

Persistent Anxiety Is Associated with Higher Glycemia Post-Transition to Adult Services in Asian Young Adults with Diabetes.

Diabetes Metab J 2020 Jun 15. Epub 2020 Jun 15.

Department of Endocrinology, Singapore General Hospital, Singapore.

Background: There is little longitudinal information on psychological burden and metabolic outcomes in young adults with diabetes (YAD) in Asia. We aimed to evaluate the association between psychological status and glycemia at baseline and 2 years following transition in a cohort of YAD in Singapore.

Methods: Subjects with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), aged 17 to 25 years, were recruited from the YAD clinic in Singapore General Hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4093/dmj.2019.0226DOI Listing

Guidelines Suggesting Children Avoid Plant-Based Milks: A Closer Examination.

Matern Child Health J 2020 Jun 30. Epub 2020 Jun 30.

Plant Based New Zealand Health Charitable Trust, Gisborne, New Zealand.

Recent Healthy Drinks, Healthy Kids (HDHK) guidelines state children between 12 and 24 months need to be consuming 2-3 cups a day of whole fat cow's milk, and less of all other beverages except water. Guidelines explicitly state plant-based milks should be avoided (with the exception of soy milk). We agree that in the first 12 months the optimal food for childhood growth is breast milk, with formula used where needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10995-020-02970-yDOI Listing

The altered circadian pattern of basal insulin requirements - an early marker of autoimmune polyendocrine syndromes in type 1 diabetes mellitus.

Endocr Regul 2020 Apr;54(2):126-132

1st Department of Psychiatry, Pavol Jozef Safarik University Faculty of Medicine, Kosice, Slovak Republic.

Objectives: The purpose of the present paper is to propose and introduce novel biomarkers of autoimmune polyendocrine syndromes that are relevant to the early diagnosis and optimal medical management of the patients who already suffer from type 1 diabetes mellitus.

Methods: We hypothesize and demonstrate on a case study that various organ-specific autoimmune endocrinopathies can result in lowered basal insulin requirements, leading to unexplained hypoglycemia.

Results: It can be hypothesized that hypothyroidism in patients with type 1 diabetes mellitus may deteriorate glycemic control and can lead to an increased rate of hypoglycemia, particularly the overnight and morning hypoglycemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/enr-2020-0015DOI Listing

Resveratrol enhances therapeutic effect on pancreatic regeneration in diabetes mellitus rats receiving autologous transplantation of adipose-derived stem cells.

Chin J Physiol 2020 May-Jun;63(3):122-127

Cardiovascular and Mitochondrial Related Diseases Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien; Department of Medical Research, China Medical University Hospital, China Medical University; Department of Biotechnology, Asia University, Taichung, Taiwan.

Pancreatic damage is the major causative agent in type 1 diabetes mellitus (DM). Several strategies have been suggested to regenerate pancreatic functions, such as stem cell transplantation and administration of active components isolating from natural herbals. This study aims to investigate if the synergistically protective effect on damaged pancreatic tissues can be observed in STZ-induced DM rats with autologous transplantation of adipose-derived stem cells (ADSC) coupling with oral administration of resveratrol. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/CJP.CJP_3_20DOI Listing

Glycaemic control improves after continuous subcutaneous insulin infusion therapy: results from an Irish regional centre for paediatric type 1 diabetes mellitus.

Ir J Med Sci 2020 Jun 25. Epub 2020 Jun 25.

Paediatric Department, University Hospital Limerick, Limerick, Ireland.

Objectives: The use of continuous subcutaneous insulin infusion (CSII) in the management of paediatric patients with type 1 diabetes mellitus (T1DM) has increased substantially in the last decade. The aim of this study was to evaluate and compare glycaemic control in a population of paediatric patients with T1DM before commencing CSII compared with 2 years after commencing CSII.

Methods: This is a retrospective study with data collection from diabetes clinic records. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11845-020-02281-9DOI Listing

Difficulties in daily life and the association with self-care ability in adults with type 1 diabetes mellitus in Japan: A cross-sectional study.

Nurs Open 2020 Jul 18;7(4):943-950. Epub 2020 Mar 18.

Division of Health Science Osaka University Graduate School of Medicine Suita Japan.

Aim: To identify the unique contents of difficulties experienced in daily life among adult type 1 diabetes mellitus patients and to determine how basic characteristics and diabetic-related self-care agency are associated with difficulties in daily life.

Methods: This study used two surveys: "Difficulties in Daily Life," which was a questionnaire developed for this survey and "Instrument of Diabetes Self-Care Agency." These two measures were then used with demographic information for cross-sectional analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nop2.466DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308687PMC

Bone Measures by Dual-Energy X-Ray Absorptiometry and Peripheral Quantitative Computed Tomography in Young Women With Type 1 Diabetes Mellitus.

J Clin Densitom 2020 May 28. Epub 2020 May 28.

Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia; Bone and Mineral Medicine, Royal Melbourne Hospital, Melbourne, Australia; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Melbourne, Australia. Electronic address:

Understanding bone fragility in young adult females with type 1 diabetes mellitus (T1DM) is of great clinical importance since the high fracture risk in this population remains unexplained. This study aimed to investigate bone health in young adult T1DM females by comparing relevant variables determined by dual-energy X-ray absorptiometry (DXA), peripheral quantitative computed tomography (pQCT) at the tibia and pQCT-based finite element analysis (pQCT-FEA) between T1DM subjects (n = 21) and age-, height- and weight-matched controls (n = 63). Tibial trabecular density (lower by 7. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocd.2020.05.009DOI Listing

Challenges of diabetes management during the COVID-19 pandemic.

Med J Aust 2020 Jun 24. Epub 2020 Jun 24.

Royal North Shore Hospital, Sydney, NSW.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja2.50665DOI Listing

Aggravated intestinal ischemia‑reperfusion injury is associated with activated mitochondrial autophagy in a mouse model of diabetes.

Mol Med Rep 2020 Jun 24. Epub 2020 Jun 24.

Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

Numerous studies have reported that diabetes is associated with an increased susceptibility to cardiac ischemia‑ reperfusion injury; however, the mechanism underlying the role of diabetes during intestinal ischemia‑reperfusion (IIR) has yet to be elucidated. The present study evaluated the intestinal pathological alterations and possible underlying mechanisms in a mouse model of type 1 diabetes mellitus with IIR. The effects of diabetes were investigated by assessing the histopathology, oxidative stress, inflammatory cytokine levels in intestine tissues and blood plasma, and protein expression levels of phosphatase and tensin homolog‑induced putative kinase (PINK1), Parkin and the ratio of light chain 3B (LC3B) II/I. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2020.11270DOI Listing

Nutritional and medical food therapies for diabetic retinopathy.

Eye Vis (Lond) 2020 18;7:33. Epub 2020 Jun 18.

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 1638 NW 10th Avenue, McKnight Building - Room 202A, Miami, FL 33136 USA.

Diabetic retinopathy (DR) is a form of microangiopathy. Reducing oxidative stress in the mitochondria and cell membranes decreases ischemic injury and end-organ damage to the retina. New approaches are needed, which reduce the risk and improve the outcomes of DR while complementing current therapeutic approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40662-020-00199-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310218PMC

Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study.

Front Immunol 2020 2;11:993. Epub 2020 Jun 2.

Nutrology and Diabetes Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

To evaluate the short term safety and potential therapeutic effect of allogenic adipose tissue-derived stromal/stem cells (ASCs) + cholecalciferol in patients with recent-onset T1D. Prospective, phase II, open trial, pilot study in which patients with recent onset T1D received ASCs (1 × 10 cells/kg) and cholecalciferol 2000 UI/day for 3 months (group 1) and were compared to controls with standard insulin therapy (group 2). Adverse events, C-peptide (CP), insulin dose, HbA1c, time in range (TIR), glucose variability (continuous glucose monitoring) and frequency of CD4FoxP3+ T-cells (flow cytometry) were evaluated at baseline (T0) and after 3 months (T3). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2020.00993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280537PMC

Urate-Lowering Therapy and Chronic Kidney Disease Progression.

Authors:
Daniel I Feig

N Engl J Med 2020 06;382(26):2567-2568

From the Department of Pediatrics, Division of Pediatric Nephrology, University of Alabama School of Medicine, Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe2015886DOI Listing

Effects of Allopurinol on the Progression of Chronic Kidney Disease.

N Engl J Med 2020 06;382(26):2504-2513

From the Department of Renal Medicine, St. George Hospital (S.V.B., A.T.), the Renal and Metabolic Division, George Institute for Global Health (S.V.B., A.T., V.P.), and St. Vincent's Clinical School (R.O.D., G.R.D.J.), University of New South Wales Medicine, the Departments of Clinical Pharmacology and Toxicology (R.O.D.) and Chemical Pathology, SydPath (G.R.D.J.), St. Vincent's Hospital, the Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney (D.C.H., G.K.R.), the Department of Renal Medicine, Westmead Hospital, Western Sydney Local Health District (D.C.H., G.K.R.), and the Department of Nephrology, the Royal North Shore Hospital (V.P.), Sydney, the Australasian Kidney Trials Network, University of Queensland (S.V.B., E.M.P., N.B., C.M.H., D.R., L.R., D.W.J.), the Department of Nephrology, Princess Alexandra Hospital, (B.D., C.M.H., D.W.J.), and the Translational Research Institute (D.W.J.), Brisbane, QLD, the Medical School, University of Western Australia, Perth (N.B.), the Department of Nephrology, Monash University at Monash Medical Centre, Melbourne, VIC (F.G.B., J.K.), Menzies School of Health Research, Charles Darwin University, Darwin, NT (A.C.), the University of Adelaide and Central Northern Adelaide Renal and Transplantation Services, Adelaide, SA (R.F.), and the Australian National University Medical School and the Department of Nephrology, Canberra Hospital, Canberra, ACT (G.W.) - all in Australia; the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom (P.C.); and the Department of Medicine, University of Auckland (N.D., J.R.Z.), and the Renal Service, Waitemata District Health Board (J.R.Z.), Auckland, the Department of Medicine, University of Otago Christchurch, Christchurch (S.C.P.), and Dunedin School of Medicine, University of Otago, Dunedin (R.J.W.) - all in New Zealand.

Background: Elevated serum urate levels are associated with progression of chronic kidney disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease who are at risk for progression is not known.

Methods: In this randomized, controlled trial, we randomly assigned adults with stage 3 or 4 chronic kidney disease and no history of gout who had a urinary albumin:creatinine ratio of 265 or higher (with albumin measured in milligrams and creatinine in grams) or an eGFR decrease of at least 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1915833DOI Listing

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.

N Engl J Med 2020 06;382(26):2493-2503

From the Research Division, Joslin Diabetes Center, and the Department of Medicine, Harvard Medical School, Boston (A.D., A.B.G., S.E.R.); the Division of Geriatrics, Institute of Gerontology (A.T.G., C.W.), the Department of Biostatistics, School of Public Health (A.T.G., C.S.), Statistical Analysis of Biomedical and Educational Research (SABER) (C.S.), and the Department of Internal Medicine, Metabolism, Endocrinology, and Diabetes (R.P.-B.), University of Michigan, Ann Arbor; the Departments of Medicine, Physiology, and Pharmacology and Toxicology (D.Z.C.) and the Division of Endocrinology and Metabolism (B.A.P.), University of Toronto, the Division of Nephrology, University Health Network (D.Z.C.), LMC Diabetes and Endocrinology (R.A.), and Lunenfeld-Tanenbaum Research Institute, Sinai Health System (B.A.P.), Toronto, the Departments of Medicine, Cardiac Sciences, and Community Health Sciences, Faculties of Medicine and Kinesiology, University of Calgary, Calgary, AB (R.J.S.), BCDiabetes, Vancouver (T.G.E.), and the Division of Endocrinology, University of Alberta, Edmonton (P.S.) - all in Canada; the Departments of Medicine and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas (I.L.); the Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (A.P.); Steno Diabetes Center, and the Department of Clinical Medicine, University Copenhagen, Copenhagen (P.R.); the Division of Nephrology, Department of Medicine, University of California, Davis (M.A.), and the Department of Pediatrics and Stanford Diabetes Research Center, Stanford University, Palo Alto (D.M.M.) - both in California; the Departments of Medicine and Pediatrics (M.L.C., W.N.R.. M.M.) and Laboratory Medicine and Pathology (A.B.K.), University of Minnesota, Minneapolis; the Division of Endocrinology and Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine (J.P.C.), and JDRF (Juvenile Diabetes Research Foundation) (M.P.), New York; the Department of Medicine (I.H.B., I.B.H.) and the Nephrology Division (K.R.T.), University of Washington, and the Institute of Translational Health Sciences, Kidney Research Institute (K.R.T.), Seattle, and Providence Health Care, Spokane (K.R.T.) - both in Washington; the Department of Medicine, Emory University, Atlanta (J.S.H., G.E.U.); the Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis (J.B.M.); the Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago (M.E.M., A.W.); the Barbara Davis Center for Diabetes, University of Colorado, Aurora (S.P.); and the Department of Medicine, State University of New York Upstate Medical University, Syracuse (R.S.W.).

Background: Higher serum urate levels are associated with an increased risk of diabetic kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1 diabetes and early-to-moderate diabetic kidney disease.

Methods: In a double-blind trial, we randomly assigned participants with type 1 diabetes, a serum urate level of at least 4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1916624DOI Listing

Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus-a probabilistic simulation model.

Transpl Int 2020 Jun 23. Epub 2020 Jun 23.

Renal Unit, Westmead Hospital, Westmead, NSW, Australia.

For patients with type 1 diabetes mellitus who progress to the point of requiring renal replacement therapy, the relative benefits of simultaneous pancreas and kidney transplantation (SPK) and deceased donor kidney transplantation across different age categories compared to dialysis are uncertain. Using Australian and New Zealand registry data from 2006 to 2016, a probabilistic Markov model (n = 10 000) was built comparing patient survival between SPK and deceased donor kidney transplantation with dialysis. Compared to dialysis, the average life years saved (LYS) and quality-adjusted life years (QALY) for SPK and deceased donor kidney transplantation were 5. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.13679DOI Listing

Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.

BMC Endocr Disord 2020 Jun 23;20(1):92. Epub 2020 Jun 23.

3U Diabetes, RCSI: University of Medicine and Health Scineces, Dublin, Ireland.

Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type 1 diabetes varies internationally and is mainly determined by the national healthcare reimbursement systems. The aim of this study is to estimate national and regional uptake of CSII therapy in children, adolescents and adults with type 1 diabetes in Ireland.

Methods: A retrospective cross-sectional study was conducted utilizing the national pharmacy claims database in 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12902-020-00573-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310521PMC

MENSTRUAL DISORDERS AND ANDROGEN-RELATED TRAITS IN YOUNG WOMEN WITH TYPE 1 DIABETES MELLITUS: A CLINICAL STUDY.

Endocr Pract 2020 Jun 23. Epub 2020 Jun 23.

Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics and University Research Institute on Maternal and Child Health and Precision Medicine, "Aghia Sophia" Children's Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

To investigate possible causes of menstrual disorders and androgen-related traits in young women with T1DM. Fifty-three women with T1DM (duration 8.0±5. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP-2020-0153DOI Listing

[Comparison of islet autoantigen-specific T cell response detected by direct enzyme-linked immunospot (ELISPOT) assay and accelerated co-cultured dendritic cells (acDCs) assay].

Zhonghua Yi Xue Za Zhi 2020 Jun;100(24):1856-1860

Department of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, the Second Xiangya Hospital, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha 410011, China.

To investigate the effect of enzyme-linked immunospot (ELISPOT) on accelerated co-cultured dendritic cells (acDCs) and direct detection of islet full-length antigen-specific T cell response in peripheral blood of patients with type 1 diabetes mellitus (T1DM). Sixteen patients with T1DM[9 males, 7 females, mean age(28.5±9. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112137-20191128-02591DOI Listing

Peripheral, synaptic and central neuronal transmission is affected in type 1 diabetes.

J Diabetes Complications 2020 May 8:107614. Epub 2020 May 8.

Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address:

Aims: We hypothesized that adults with type 1 diabetes and severe polyneuropathy have alterations in neuronal transmission at different anatomical levels. The aims were to investigate upstream sensory neuronal activation in terms of peripheral, spinal, precortical, and cortical transmission.

Methods: 48 participants with type-1 diabetes and polyneuropathy, and 21 age-matched healthy participants were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2020.107614DOI Listing